Goldman Sachs has initiated coverage of Vera Therapeutics (VERA) with a buy rating, citing its drug candidate atacicept and a ...

Goldman Sachs analyst Paul Choi initiated coverage of Vera Therapeutics (VERA) with a Buy rating and $58 price target Following the recent pullback, the firm sees Vera shares as at “an ...

Goldman Sachs staffers are griping about getting paltry bonuses — despite a massive raise given to CEO David Solomon after the bank posted its best earnings in three years, The Post has learned.

Last week, hedge funds fled their bets on tech stocks, a Goldman Sachs (GS.N), opens new tab note from Friday and seen by Reuters Monday showed. The data, from Goldman's prime brokerage desk ...

Earnings Report 12.552 USD Q1 2025 Earnings Release 04/14/2025 Earnings Report 11.100 USD Q2 2025 Earnings Release 07/16/2025 Earnings Report 11.165 USD Q3 2025 Earnings Release 10/14/2025 ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Armen Avanessians, global head and CIO of the platform within Goldman Sachs Asset Management, retired in April 2022 after 36 years at the firm, yet this departure hasn’t immediately affected the ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...